Deutsche Bank Ag\ Imara Inc. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.25 - $4.05 $225 - $405	-100 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$4.08 - $7.83 $87,324 - $167,585	-21,403 Reduced 99.53%	100 $0
Q2 2021 Aug 11, 2021	BUY	$6.78 - $9.04 $68,627 - $91,502	10,122 Added 88.94%	21,503 $170,000
Q1 2021 May 13, 2021	BUY	$8.18 - $23.98 $47,100 - $138,076	5,758 Added 102.4%	11,381 $96,000
Q4 2020 Feb 16, 2021	BUY	$15.81 - $29.0 $45,153 - $82,824	2,856 Added 103.22%	5,623 $124,000
Q3 2020 Nov 12, 2020	BUY	$18.75 - $28.58 $4,462 - $6,802	238 Added 9.41%	2,767 $56,000
Q2 2020 Aug 13, 2020	BUY	$15.6 - $54.87 $39,452 - $138,766	2,529 New	2,529 $70,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.